<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2013-03-05 14:55:30American College of Allergy Asthma & Immunology Allergen immunotherapy Immunotherapy Sublingual immunotherapy Allergy World Allergy Organization Allergen Omalizumab Thomas Platts-Mills Medicine Immunology American Academy of Allergy Asthma and Immunology |
Add to Reading List |
Tuesday, March 5, 2013 Contact: Megan Brown [removed[removed] | April 18, 2018 Torii Pharmaceutical Co., Ltd. Price Listing on the NHI Reimbursement List and Launch of “CEDARCURE® Japanese Cedar Pollen Sublingual Tablets”, an Allergen Immunotherapy Tablet for Japanese Cedar PollDocID: 1uM8x - View Document |
| 第42回 日本免疫学会学術集会 クリニカルセミナー 2 Sublingual immunotherapy for Japanese cedar pollinosisDocID: 1untY - View Document |
| ALK in brief Fighting the cause of allergy 2DocID: 1fNuw - View Document |
| NEWS RELEASE Embargoed untilJuly 11th 2011 New Treatment offers Hope for Peanut Allergic Children A recent study was undertaken to evaluate the efficacy and safety of sublingual immunotherapy (SLIT) in peanut-alleDocID: 1bUl2 - View Document |
| Revised Tech Op for PostingDocID: 1aZPy - View Document |